Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Health Canada Approves Merck's Keytruda In Combination With Enfortumab Vedotin For Adult Patients With Unresectable Locally Advanced Or Metastatic Urothelial Cancer With No Prior Systemic Therapy

Author: Benzinga Newsdesk | August 22, 2024 07:10am

Posted In: MRK